News

Jiangsu Hengrui Pharma has secured a landmark regulatory clearance in China for its oral thrombopoietin (TPO) receptor agonist hetrombopag, making it the first oral TPO agonist anywhere in the world to receive approval for chemotherapy-induced thrombocytopenia (CIT). The approval...

Introduction For e-commerce platforms, hospital procurement directors, healthcare supply chain managers, and medical device importers, hearing aid sourcing has moved far beyond simple price-per-unit comparisons. The international medical device landscape now demands verifiable regulatory compliance, robust factory documentation, and data...

Gilead Sciences has expanded its R&D infrastructure with a new 182,000-square-foot facility in Foster City dedicated to inflammation, oncology, and data science.

Research Peptides in Modern Drug Discovery: Quality, Purity, and Sourcing Standards Peptides have been a part of research for many years. The way scientists handle peptides has changed a lot. New methods for making them, better tools to analyze them,...

In recent years, biomarkers have become an essential part of patient evaluation and are driving the overall therapeutic strategy. Accurate molecular profiling of the tumor before any intervention is an essential component of effective treatment planning for stage 4...

The quote said 98.5%. The certificate that arrived nine days later said 96.1%, and it covered a batch that had already gone into a dose-response series. We repeated the work. The reagent cost was trivial; the three weeks were...

Boehringer Ingelheim has joined other pharmaceutical leaders in deploying Owkin's agentic AI scientist, K Pro, to analyze multimodal patient data in oncology and immunology R&D.